Rainier is a PhD candidate at the Centre for Health Economics, Monash University, researching the cost-effectiveness of immunoglobulin therapy for preventing infections in patients with multiple myeloma. Experience in administrative linked data analysis, simulation modelling, health economic evaluation and time to event methods.